BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2017
View Archived Issues
MAX BioPharma obtains proof-of-concept data on Oxy-200 for osteoporosis
Read More
GeoVax's LASV vaccine candidate shows efficacy in animal model
Read More
FDA awards orphan drug status to Principia Biopharma's PRN-1008
Read More
Regulatory update for tucatinib in Europe
Read More
Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors
Read More
Merck & Co. discloses Nav1.7 blockers
Read More
Bristol-Myers Squibb divulges apelin receptor agonists
Read More
Gilead Sciences patents TBK1 and IKK-E kinase inhibitors
Read More
Novartis presents guanylate cyclase activators
Read More
FDA issues complete response letter regarding Dextenza NDA
Read More
ViraCyte completes phase I study of Viralym-C
Read More
Nektar Therapeutics describes activity of autoimmune disease candidate NKTR-358
Read More
Daiichi Sankyo enters cancer reseach agreement with Max Planck and Lead Discovery Center
Read More
First-in-human results for inactivated influenza vaccine delivered by microneedle patch
Read More
First patient dosed in phase I study of ARQ-531
Read More
Novel TER ATPase inhibitor OSSL-325096 developed for treating multiple myeloma
Read More
CURE Pharmaceutical, Therapix to enter research collaboration with Assuta Medical Centers
Read More
MedigenixBio tests new antithrombotic compound MDI-2001 in vivo
Read More
FDA advisory committee votes in favor of Mylotarg for newly diagnosed AML
Read More
Amicus plans migalastat NDA for Fabry disease based on FDA communications
Read More
Xadago launched in U.S.
Read More
FDA grants full approval to Blincyto for B-cell precursor ALL
Read More
First-in-human study finds TFPI inhibitor PF-06741086 well tolerated
Read More
